tiprankstipranks
Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI
Holding BTAI?
Track your performance easily

Bioxcel Therapeutics (BTAI) Financial Statements

1,342 Followers

Bioxcel Therapeutics Financial Overview

Bioxcel Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.151; its P/E ratio is -0.22; Bioxcel Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 214.00K$ 1.10M$ 582.00K$ 376.00K$ 341.00K
Gross Profit$ -956.00K$ 1.04M$ 502.00K$ -337.00K$ -171.00K
EBIT$ -9.97M$ -4.70M$ -23.18M$ -18.82M$ -47.23M
EBITDA$ -9.71M$ -4.45M$ -22.99M$ -18.74M$ -47.16M
Net Income Common Stockholders$ -13.65M$ -8.30M$ -26.79M$ -22.26M$ -50.49M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 40.39M$ 56.27M$ 74.14M$ 65.22M$ 89.96M
Total Assets$ 48.89M$ 65.44M$ 82.32M$ 73.70M$ 100.45M
Total Debt$ 104.60M$ 103.26M$ 101.98M$ 101.04M$ 99.62M
Net Debt$ 64.21M$ 46.99M$ 27.84M$ 35.82M$ 9.66M
Total Liabilities$ 134.53M$ 139.27M$ 154.69M$ 130.21M$ 141.06M
Stockholders Equity$ -85.63M$ -74.30M$ -72.36M$ -56.51M$ -40.61M
Cash Flow-
Free Cash Flow$ -16.34M$ -23.17M$ -17.71M$ -26.86M$ -37.58M
Operating Cash Flow$ -16.34M$ -23.17M$ -17.71M$ -26.86M$ -37.58M
Investing Cash Flow-----
Financing Cash Flow$ 454.00K$ 5.30M$ 26.63M$ 2.12M-
Currency in USD

Bioxcel Therapeutics Earnings and Revenue History

Bioxcel Therapeutics Debt to Assets

Bioxcel Therapeutics Cash Flow

Bioxcel Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis